Tenaya Therapeutics (TNYA) Common Equity (2020 - 2026)
Tenaya Therapeutics (TNYA) posted Common Equity of $69.41 million for Q2 2026, down 30.5% from $99.83 million a year earlier and down 34.6% from the prior quarter.
Powered by 
Analysis
Tenaya Therapeutics (TNYA) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Tenaya Therapeutics' Common Equity came in at $123.27 million, up 32.8% from FY2024.
- In prior years, Tenaya Therapeutics' Common Equity was $92.85 million in FY2024 (-33.4%), $139.42 million in FY2023 (-42.7%), $243.38 million in FY2022 (-12.6%) and $278.53 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Common Equity since Q2 2021.
- On a year-over-year basis, Common Equity increased in 1 of the last eight quarters, with an average decline of 18.8%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 32.8%; the weakest was Q4 2023, with a decline of 42.7%.
- According to Business Quant data, Common Equity for the three prior quarters was $106.19 million (Q1 2026), $123.27 million (Q4 2025) and $82.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Tenaya Therapeutics | 134.54 Mn | 134.54 Mn | - | 69.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.41 Mn |
| Mar 31, 2026 | 106.19 Mn |
| Dec 31, 2025 | 123.27 Mn |
| Sep 30, 2025 | 82.87 Mn |
| Jun 30, 2025 | 99.83 Mn |
| Mar 31, 2025 | 119.40 Mn |
| Dec 31, 2024 | 92.85 Mn |
| Sep 30, 2024 | 112.60 Mn |
| Jun 30, 2024 | 134.00 Mn |
| Mar 31, 2024 | 158.18 Mn |
| Dec 31, 2023 | 139.42 Mn |
| Sep 30, 2023 | 164.88 Mn |
| Jun 30, 2023 | 189.94 Mn |
| Mar 31, 2023 | 215.41 Mn |
| Dec 31, 2022 | 243.38 Mn |
| Sep 30, 2022 | 196.33 Mn |
| Jun 30, 2022 | 223.87 Mn |
| Mar 31, 2022 | 249.10 Mn |
| Dec 31, 2021 | 278.53 Mn |
| Sep 30, 2021 | 303.70 Mn |
API Access
Tenaya Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TNYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TNYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TNYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();